What insulin dose should be started for a patient with a fasting blood glucose of 240 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Insulin Dosing for Fasting Blood Glucose of 240 mg/dL

Start with 10 units of basal insulin (such as NPH, glargine, or detemir) given at bedtime, or alternatively 0.1-0.2 units/kg/day if weight-based dosing is preferred. 1, 2

Initial Dosing Strategy

For a patient with fasting blood glucose of 240 mg/dL (13.3 mmol/L), the standard approach is conservative initiation followed by systematic titration:

  • Begin with 10 units of basal insulin at bedtime if targeting fasting hyperglycemia specifically 3, 2
  • Alternatively, use 0.1-0.2 units/kg/day as the starting dose 1, 2, 4
  • If considering twice-daily premixed insulin (targeting both fasting and postprandial glucose), start with 6-10 units twice daily 3

Titration Protocol

The key to success is aggressive, algorithm-driven titration rather than remaining at the initial dose. Titrate every 3-4 days based on fasting glucose readings: 1, 5

Simple Titration Algorithm:

  • Fasting glucose <4.4 mmol/L (<79 mg/dL): Decrease by 2 units 1
  • Fasting glucose 4.4-7.0 mmol/L (79-126 mg/dL): No change 1
  • Fasting glucose 7.1-10.0 mmol/L (128-180 mg/dL): Increase by 2 units 1
  • Fasting glucose >10.0 mmol/L (>180 mg/dL): Increase by 4 units 1

Alternative Patient-Managed Titration:

  • Increase by 2 units every 3 days until fasting glucose reaches target of 80-130 mg/dL (4.4-7.2 mmol/L), provided no hypoglycemia occurs 5, 4
  • For longer-acting insulins (glargine 300 units/mL, degludec), can increase by 2-4 units once or twice weekly 2

Target Goals

  • Fasting plasma glucose: 80-130 mg/dL (4.4-7.2 mmol/L) 4
  • Optimal target for titration is <100 mg/dL (<5.5 mmol/L) to achieve HbA1c <7% 5
  • Two-hour postprandial glucose: <180 mg/dL 4

Expected Outcomes and Doses

  • Most patients achieve adequate control with 40-70 units/day of basal insulin 3
  • Approximately 50% of patients reach HbA1c ≤7% with appropriate titration 3
  • Expected HbA1c reduction of 1.5-2.5% with insulin initiation 3
  • Doses may need to increase up to 0.5-1.0 units/kg/day in some cases 2

Critical Pitfalls to Avoid

Overbasalization is a common error—continuing to escalate basal insulin doses without meaningful fasting glucose reduction. 2 If basal insulin exceeds approximately 0.5 units/kg/day without achieving targets, consider:

  • Adding prandial insulin (start with 4 units with largest meal or 10% of basal dose) 1
  • Adding or optimizing GLP-1 receptor agonist therapy 1
  • Re-evaluating the overall treatment regimen rather than further increasing basal insulin 2

Additional Considerations

  • Weight gain of approximately 3 kg over 6 months is expected 3
  • If hypoglycemia occurs without clear cause, reduce the corresponding dose by 10-20% 1
  • Continue metformin (up to 2,550 mg/day) alongside insulin therapy 6
  • For HbA1c <8%, consider lowering basal dose by 4 units or 10% when adding prandial insulin 1

References

4
Research

Type 2 Diabetes Mellitus: Outpatient Insulin Management.

American family physician, 2018

Related Questions

Can NPH insulin be increased by 2 units every three days in adult patients?
What overnight glucose pattern and basal insulin dose adjustment are recommended for an adult female with type 2 diabetes, bedtime blood glucose 126 mg/dL after 12 units of Lantus (insulin glargine), prior bedtime glucose 168 mg/dL after 16 units, morning glucose 132 mg/dL, HbA1c 8 %, and a 1:50 AM glucose reading of 96 mg/dL?
In a 41-year-old woman with type 2 diabetes, weight 110 kg, taking olanzapine (Zyprexa) 5 mg twice daily and furosemide (Lasix) 40 mg daily, with a current insulin‑to‑carbohydrate ratio of 1 unit per 12 g carbs, insulin sensitivity factor of 50 mg/dL per unit, and blood glucose readings of 364 mg/dL at 11:00 after a 69‑g carbohydrate meal and 409 mg/dL at 17:00, what should her insulin sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin (Lantus, insulin glargine) dose be?
For a 45-year-old Hispanic male weighing 98.4 kg with newly diagnosed type 2 diabetes and normal renal function, currently on 30 U insulin glargine (Lantus) and an insulin-to-carbohydrate ratio of 1 U per 5 g carbohydrate, with post‑meal insulin drip rates of 6, 4, 8, 6 U and overnight fasting drip rates of 2 U each hour, what should the insulin-to-carbohydrate ratio, basal insulin glargine dose, and insulin sensitivity factor be?
Can an adult with diabetes safely use Delsym (dextromethorphan polistirex) for cough, and what dosing and monitoring are recommended?
What is the recommended management for a psychotic patient currently using benzodiazepines and cocaine with a past history of opioid use?
How should I evaluate and manage a patient with dysuria, no burning or urgency, and only a trace of hematuria?
Should sildenafil be taken before or after a meal?
What are the symptoms of mastocytosis without known triggers?
If a patient's postprandial glucose is 300 mg/dL, how many units of rapid‑acting insulin (e.g., insulin lispro, insulin aspart, or regular insulin) should be administered?
What is the appropriate management for a 2‑month‑old infant with a 5 mm chronic subdural hematoma, normal Glasgow Coma Scale, presenting with a febrile seizure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.